PharmiWeb.com - Global Pharma News & Resources
20-Feb-2020

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, Feb. 20, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Acceleron Pharma Inc. (NASDAQ: XLRN).

If you are a shareholder of Acceleron Pharma Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:

http://pjlfirm.com/acceleron-pharma-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http://pjlfirm.com.  Attorney advertising. Prior results do not guarantee a similar outcome. 

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-purcell-julie--lefkowitz-llp-is-investigating-acceleron-pharma-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-301008708.html

SOURCE Purcell Julie & Lefkowitz LLP

Editor Details

Last Updated: 20-Feb-2020